The purpose of this paper was to investigate the short-term variability in cell-free DNA (cfDNA), aspartate aminotransferase (AST), and creatinine kinase (CK) levels by comparing levels in plasma obtained at defined intervals over the course of 75 min. The effects of blood pressure, hematocrit, pulse, or reported level of anxiety or pain at collection time or average frequency of physical exercise on cfDNA concentration were also investigated.
Biological variability of cell-free DNA in healthy females at rest within a short time course.
Brodbeck K, Schick S, Bayer B, Anslinger K, Krüger K, Mayer Z, Holdenrieder S, Peldschus S
Purpose
Conclusion
cfDNA, AST, and CK levels varied among the timepoints in all patients but the only significant difference from initial levels was lower AST in the specimens collected after 10 min. cfDNA was not significantly affected by blood pressure, hematocrit, pulse, or reported level of anxiety or pain at collection time or average frequency of physical exercise reported by the patient.
Studies (1)
Purpose
The purpose of this study was to investigate the short-term variability in cfDNA, AST, and CK levels by comparing levels in plasma obtained at defined intervals over the course of 75 min. The effects of blood pressure, hematocrit, pulse, and reported level of anxiety or pain at collection time or average frequency of physical exercise on cfDNA concentration were also investigated. EDTA blood was obtained by peripheral intravenous catheter from 14 healthy females immediately after venipuncture and then again for 2-4 additional timepoints over the course of 75 min (at 5, 10, 15, 20, 30, 40, 45, 60, or 75 min). Plasma was obtained by centrifugation at 1600 x g for 10 min followed by recentrifugation of the plasma at 4500 x g for 10 min within 2 h of blood draw. Plasma aliquots were frozen at -80°C for 9 months before DNA isolation using the Norgen Plasma/Serum Circulating DNA Purification Mini Kit. DNA concentration was evaluated using the real-time qRT-PCR based Quantifiler Trio DNA Quantification Kit. CK and AST levels were evaluated in blood specimens obtained at 0, 5, 10, 15 (only some), 20, 30, and 40 min using a Cobas c 501 system.
Summary of Findings
cfDNA concentration was quantifiable in 61 of 62 specimens with a median concentration of 1.4 ng/mL. The highest median cfDNA concentration was in the initial collection and the lowest at 20 min but the difference was not significant. Importantly, while the cfDNA concentrations in plasma from individual patients fluctuated 11.8-38.5% among the timepoints, there was no trend observed in the direction of the fluctuations. Fold-change in cfDNA concentration ranged from 0.4-1.6. cfDNA was not significantly affected by blood pressure, hematocrit, pulse, or reported level of anxiety or pain at collection time or average frequency of physical exercise reported by the patient. Fold-changes of 0.7-1.1 in CK levels and 0.6-1.2 in AST levels were found over the time-course but the only significant difference from the initial collection was lower AST levels in the specimen collected after 10 min (P=0.03).
Biospecimens
FluidBloodFluidPlasmaPreservation Types
FrozenDiagnoses
NormalPlatforms
DNAReal-time qPCRProteinClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Blood pressure Diastolic median 73 mmHg (IQR of 68–80)Systolic median 120 mmHg (IQR of 110–128)Preaquisition Diagnosis/ patient condition Hematocrit 39-41Nervousness score (range not stated)Pain associated with cannula (range not stated)Pain associated with cannula (scores range not stated)Pulse 50-88Biospecimen Acquisition Time of biospecimen collection 0 min after venipuncture10 min after venipuncture15 min after venipuncture20 min after venipuncture30 min after venipuncture40 min after venipuncture45 min after venipuncture5 min after venipuncture60 min after venipuncture75 min after venipunctureBiospecimen Aliquots and Components Aliquot sequential collection 1st collection2nd collection3rd collection4th collection5th collection